Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection

NCT00006178 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Kidney Failure

Interventions

DRUG: Sirolimus
DRUG: Thymoglobulin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)